OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Navigating the Complex Landscape of Ebola Infection Treatment: A Review of Emerging Pharmacological Approaches
Francisca Almeida-Pinto, Rui Pinto, João Rocha
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 21-55
Open Access | Times Cited: 7
Francisca Almeida-Pinto, Rui Pinto, João Rocha
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 21-55
Open Access | Times Cited: 7
Showing 7 citing articles:
Minor electrostatic changes robustly increase VP40 membrane binding, assembly, and budding of Ebola virus matrix protein derived virus-like particles
Balindile B. Motsa, Tej Sharma, Michael D. Cioffi, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 5, pp. 107213-107213
Open Access | Times Cited: 3
Balindile B. Motsa, Tej Sharma, Michael D. Cioffi, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 5, pp. 107213-107213
Open Access | Times Cited: 3
Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4′-fluorouridine
Leon Schrell, Hannah L Fuchs, Antje Dickmanns, et al.
Antiviral Research (2024) Vol. 233, pp. 106046-106046
Open Access | Times Cited: 3
Leon Schrell, Hannah L Fuchs, Antje Dickmanns, et al.
Antiviral Research (2024) Vol. 233, pp. 106046-106046
Open Access | Times Cited: 3
Ebola disease: bridging scientific discoveries and clinical application
Amanda Rojek, Joshua Fieggen, Paska Apiyo, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 1
Amanda Rojek, Joshua Fieggen, Paska Apiyo, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 1
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection
Fan Bu, Gang Ye, Kimberly M. Morsheimer, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 12, pp. e1012817-e1012817
Open Access | Times Cited: 1
Fan Bu, Gang Ye, Kimberly M. Morsheimer, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 12, pp. e1012817-e1012817
Open Access | Times Cited: 1
Minor changes in electrostatics robustly increase VP40 membrane binding, assembly, and budding of Ebola virus matrix protein derived virus-like particles
Balindile B. Motsa, Tej Sharma, Prem P. Chapagain, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Balindile B. Motsa, Tej Sharma, Prem P. Chapagain, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4′-fluorouridine
Leon Schrell, Hannah L Fuchs, Antje Dickmanns, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Leon Schrell, Hannah L Fuchs, Antje Dickmanns, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses
Malaika D. Argade, Jazmin Galván Achi, Ryan Bott, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Malaika D. Argade, Jazmin Galván Achi, Ryan Bott, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
